Correction to: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics (Nature, (2024), 631, 8019, (189-198), 10.1038/s41586-024-07575-x)
Issued Date
2024-01-01
Resource Type
ISSN
00280836
eISSN
14764687
Scopus ID
2-s2.0-85200231755
Journal Title
Nature
Rights Holder(s)
SCOPUS
Bibliographic Citation
Nature (2024)
Suggested Citation
Lindeboom R.G.H., Worlock K.B., Dratva L.M., Yoshida M., Scobie D., Wagstaffe H.R., Richardson L., Wilbrey-Clark A., Barnes J.L., Kretschmer L., Polanski K., Allen-Hyttinen J., Mehta P., Sumanaweera D., Boccacino J.M., Sungnak W., Elmentaite R., Huang N., Mamanova L., Kapuge R., Bolt L., Prigmore E., Killingley B., Kalinova M., Mayer M., Boyers A., Mann A., Swadling L., Woodall M.N.J., Ellis S., Smith C.M., Teixeira V.H., Janes S.M., Chambers R.C., Haniffa M., Catchpole A., Heyderman R., Noursadeghi M., Chain B., Mayer A., Meyer K.B., Chiu C., Nikolić M.Z., Teichmann S.A. Correction to: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics (Nature, (2024), 631, 8019, (189-198), 10.1038/s41586-024-07575-x). Nature (2024). doi:10.1038/s41586-024-07838-7 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/100394
Title
Correction to: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics (Nature, (2024), 631, 8019, (189-198), 10.1038/s41586-024-07575-x)
Author(s)
Lindeboom R.G.H.
Worlock K.B.
Dratva L.M.
Yoshida M.
Scobie D.
Wagstaffe H.R.
Richardson L.
Wilbrey-Clark A.
Barnes J.L.
Kretschmer L.
Polanski K.
Allen-Hyttinen J.
Mehta P.
Sumanaweera D.
Boccacino J.M.
Sungnak W.
Elmentaite R.
Huang N.
Mamanova L.
Kapuge R.
Bolt L.
Prigmore E.
Killingley B.
Kalinova M.
Mayer M.
Boyers A.
Mann A.
Swadling L.
Woodall M.N.J.
Ellis S.
Smith C.M.
Teixeira V.H.
Janes S.M.
Chambers R.C.
Haniffa M.
Catchpole A.
Heyderman R.
Noursadeghi M.
Chain B.
Mayer A.
Meyer K.B.
Chiu C.
Nikolić M.Z.
Teichmann S.A.
Worlock K.B.
Dratva L.M.
Yoshida M.
Scobie D.
Wagstaffe H.R.
Richardson L.
Wilbrey-Clark A.
Barnes J.L.
Kretschmer L.
Polanski K.
Allen-Hyttinen J.
Mehta P.
Sumanaweera D.
Boccacino J.M.
Sungnak W.
Elmentaite R.
Huang N.
Mamanova L.
Kapuge R.
Bolt L.
Prigmore E.
Killingley B.
Kalinova M.
Mayer M.
Boyers A.
Mann A.
Swadling L.
Woodall M.N.J.
Ellis S.
Smith C.M.
Teixeira V.H.
Janes S.M.
Chambers R.C.
Haniffa M.
Catchpole A.
Heyderman R.
Noursadeghi M.
Chain B.
Mayer A.
Meyer K.B.
Chiu C.
Nikolić M.Z.
Teichmann S.A.
Author's Affiliation
hVIVO Services Limited
UCL Division of Medicine
Department of Physics
University of Cambridge
University College London Hospitals NHS Foundation Trust
University College London
The Netherlands Cancer Institute
Imperial College London
Mahidol University
UCL Great Ormond Street Institute of Child Health
Wellcome Sanger Institute
Biodata Innovation Centre
UCL Division of Medicine
Department of Physics
University of Cambridge
University College London Hospitals NHS Foundation Trust
University College London
The Netherlands Cancer Institute
Imperial College London
Mahidol University
UCL Great Ormond Street Institute of Child Health
Wellcome Sanger Institute
Biodata Innovation Centre
Corresponding Author(s)
Other Contributor(s)
Abstract
Correction to: Naturehttps://doi.org/10.1038/s41586-024-07575-x Published online 19 June 2024 In the version of the article initially published, the Acknowledgements was missing the following text, which has now been added to the HTML and PDF versions of the article: “The authors gratefully acknowledge support from the UK Vaccine Taskforce of the Department of Business, Energy and Industrial Strategy of Her Majesty’s Government (BEIS). We thank the following organizations for their invaluable contributions to development and implementation of the SARS-CoV-2 human challenge project: the Royal Free London NHS Foundation Trust, Human Infection Challenge Network for Vaccine Development (HIC-Vac), NIHR Clinical Research Network staff at the Royal Bolton Hospital, and ISARIC4C Investigators (https://isaric4c.net/about/authors/) for providing the clinical material for challenge virus production. C.C. is supported by the NIHR Imperial Biomedical Research Centre (BRC) award to Imperial College Healthcare NHS Trust and Imperial College London. ISARIC4C is funded by the National Institute for Health Research (NIHR; award CO-CIN-01), the Medical Research Council (MRC; grant MC_PC_19059), the NIHR Health Protection Research Unit in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE), in collaboration with Liverpool School of Tropical Medicine and the University of Oxford (NIHR award 200907), Liverpool Experimental Cancer Medicine Centre provided infrastructure support for this research (grant reference C18616/A25153) and NIHR Health Protection Research Unit in Respiratory Infections (NIHR award 200927). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, DHSC or BEIS.”
